Clinical Trial Update: Ultrasound in Assessing Antiangiogenic Treatment in Patients With Advanced Kidney Cancer [NA]

View source ↗

Summary

This clinical trial update describes using ultrasound to assess antiangiogenic therapy in patients with advanced renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: National Cancer Institute, France | Conditions: Kidney Cancer, Metastatic Cancer | NA | Status: UNKNOWN